Hitto Kaufmann - PIRS Old VP Officer
Insider
Hitto Kaufmann is VP Officer of PIRS Old
| Age | 53 |
| Phone | 857 246 8998 |
| Web | https://www.pieris.com |
Hitto Kaufmann Latest Insider Activity
Tracking and analyzing the buying and selling activities of Hitto Kaufmann against PIRS Old stock is an integral part of due diligence when investing in PIRS Old. Hitto Kaufmann insider activity provides valuable insight into whether PIRS Old is net buyers or sellers over its current business cycle. Note, PIRS Old insiders must abide by specific rules, including filing SEC forms every time they buy or sell PIRS Old'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Hitto Kaufmann over six months ago Acquisition by Hitto Kaufmann of 215819 shares of Pieris Pharmaceuticals at 3.03 subject to Rule 16b-3 |
PIRS Old Management Efficiency
The company has return on total asset (ROA) of (0.1318) % which means that it has lost $0.1318 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8046) %, meaning that it created substantial loss on money invested by shareholders. PIRS Old's management efficiency ratios could be used to measure how well PIRS Old manages its routine affairs as well as how well it operates its assets and liabilities.PIRS Old currently holds 11.92 M in liabilities with Debt to Equity (D/E) ratio of 0.3, which may suggest the company is not taking enough advantage from borrowing. PIRS Old has a current ratio of 2.51, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about PIRS Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| MSc MBA | Inozyme Pharma | 53 | |
| Matthew CPA | PDS Biotechnology Corp | 55 | |
| Amanda Hamilton | ADC Therapeutics SA | N/A | |
| Weidong Zhong | Terns Pharmaceuticals | 58 | |
| Augustine Lawlor | Leap Therapeutics | 68 | |
| Mark Vignola | Terns Pharmaceuticals | 47 | |
| Kenneth MD | Cue Biopharma | 64 | |
| Kerry MD | Terns Pharmaceuticals | N/A | |
| Dr DPHIL | ADC Therapeutics SA | 65 | |
| MS MBA | ADC Therapeutics SA | 52 | |
| Murray MD | X4 Pharmaceuticals | 63 | |
| Andreas MD | Affimed NV | 64 | |
| Mark OMahony | Leap Therapeutics | 54 | |
| Iraj Ali | Achilles Therapeutics PLC | 50 | |
| Kimberly Pope | ADC Therapeutics SA | 58 | |
| Janetta Trochimiuk | PDS Biotechnology Corp | 62 | |
| Richard MD | Corvus Pharmaceuticals | 74 | |
| Arthur Taveras | X4 Pharmaceuticals | 61 | |
| Lisa Skelton | ADC Therapeutics SA | 53 | |
| Helen MBA | Adaptimmune Therapeutics Plc | 58 | |
| Regina Grebla | Agenus Inc | N/A | |
Management Performance
| Return On Equity | -0.8 | |||
| Return On Asset | -0.13 |
PIRS Old Leadership Team
Elected by the shareholders, the PIRS Old's board of directors comprises two types of representatives: PIRS Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PIRS. The board's role is to monitor PIRS Old's management team and ensure that shareholders' interests are well served. PIRS Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PIRS Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Maria Kelman, Executive Relations | ||
| Thomas Bures, Senior CFO | ||
| Prompong Chaikul, Chief Officer | ||
| Ahmed JD, Chief VP | ||
| Gordon MD, Head Oncology | ||
| Stephen JD, President CEO | ||
| Florian Witte, VP Leadership | ||
| Christine Rothe, VP Science | ||
| Hitto Kaufmann, VP Officer | ||
| Frank Vollmering, Vice Resources | ||
| Shane Olwill, Senior Officer |
PIRS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PIRS Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.8 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (1.14) % | |||
| Operating Margin | (0.57) % | |||
| Current Valuation | (8.41 M) | |||
| Shares Outstanding | 1.32 M | |||
| Shares Owned By Insiders | 0.06 % | |||
| Shares Owned By Institutions | 52.92 % | |||
| Number Of Shares Shorted | 23.56 K | |||
| Price To Earning | (6.95) X |
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in PIRS Stock
If you are still planning to invest in PIRS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PIRS Old's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stocks Directory Find actively traded stocks across global markets |